Cargando…

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry

Mostrar otras versiones (1)

Effective small molecule therapies to combat the SARS-CoV-2 infection are still lacking as the COVID-19 pandemic continues globally. High throughput screening assays are needed for lead discovery and optimization of small molecule SARS-CoV-2 inhibitors. In this work, we have applied viral pseudotypi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Miao, Pradhan, Manisha, Gorshkov, Kirill, Petersen, Jennifer D., Shen, Min, Guo, Hui, Zhu, Wei, Klumpp-Thomas, Carleen, Michael, Sam, Itkin, Misha, Itkin, Zina, Straus, Marco R., Zimmerberg, Joshua, Zheng, Wei, Whittaker, Gary R., Chen, Catherine Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509088/ https://www.ncbi.nlm.nih.gov/pubmed/34642691 http://dx.doi.org/10.1101/2021.10.04.463106

Ejemplares similares

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022)

Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
por: Chen, Catherine Z., et al.
Publicado: (2020)

Identification of SARS-CoV-2 viral entry inhibitors using machine learning and cell-based pseudotyped particle assay
por: Sun, Hongmao, et al.
Publicado: (2021)

The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators
por: Gorshkov, Kirill, et al.
Publicado: (2020)

A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
por: Shrimp, Jonathan H., et al.
Publicado: (2022)

The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
por: Gorshkov, Kirill, et al.
Publicado: (2020)

High Throughput Screening of Protease Inhibitor Libraries Using a Novel Dual Pseudotype-Based Assay for SARS-CoV Entry
por: Zhou, Yanchen, et al.
Publicado: (2009)

Identifying Small Molecule Compounds that Have Synergistic Effects With Cisplatin and Other Platinum Drugs Using High Throughput Matrix Screening
por: Al-Zubi, Layla, et al.
Publicado: (2022)

Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
por: Hu, Xin, et al.
Publicado: (2021)

Cell-Based No-Wash Fluorescence Assays for Compound Screens Using a Fluorescence Cytometry Plate Reader
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay
por: Urbanowicz, Richard A., et al.
Publicado: (2016)

The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Challenges on the development of a pseudotyping assay for Zika glycoproteins
por: Ruiz-Jiménez, Fernando, et al.
Publicado: (2021)

Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors
por: Siegert, Sandra, et al.
Publicado: (2005)

Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System
por: Tani, Hideki
Publicado: (2014)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
por: Lang, Martin, et al.
Publicado: (2023)

Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid
por: Gorshkov, Kirill, et al.
Publicado: (2020)

An OpenData portal to share COVID-19 drug repurposing data in real time
por: Brimacombe, Kyle R., et al.
Publicado: (2020)

Pricing derivatives under Lévy models: modern finite-difference and pseudo-differential operators approach
por: Itkin, Andrey
Publicado: (2017)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
por: Kononova, A. A., et al.
Publicado: (2017)

mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer
por: Kumari, Anju, et al.
Publicado: (2023)

ATRT-11. DEVELOPMENT OF NOVEL PRECLINICAL MODELS AND THERAPEUTIC STRATEGIES FOR ETMR
por: Cocito, Carolina, et al.
Publicado: (2023)

Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
por: Carnell, George William, et al.
Publicado: (2015)

Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
por: Ferrara, Francesca, et al.
Publicado: (2016)

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis
por: Ferrara, Francesca, et al.
Publicado: (2018)

Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry
por: Lin, Han-Xin, et al.
Publicado: (2011)

Pseudotyped Vesicular Stomatitis Virus for Analysis of Virus Entry Mediated by SARS Coronavirus Spike Proteins
por: Fukushi, Shuetsu, et al.
Publicado: (2007)

Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages
por: Stantchev, Tzanko S., et al.
Publicado: (2019)

Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection
por: Shamim, Khalida, et al.
Publicado: (2021)

A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
por: Khetawat, Dimple, et al.
Publicado: (2010)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
por: Zhu, Wei, et al.
Publicado: (2020)

Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening
por: Zhu, Wei, et al.
Publicado: (2020)

New-onset chilblains in close temporal association to mRNA-1273 vaccination
por: Kha, Connie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i88pdhvi461s3taaashved4dl0